News

Filter

Current filters:

Cardio-vascular

501 to 510 of 97252 results

Global Pharma may suspend production of vital drugs for Russia

07-11-2014

Global pharmaceutical producers are considering suspending of production of vital drugs for the Russian…

FinancialPharmaceuticalPricingProductionRussia

Vectura gets VR315 US development milestone

07-11-2014

UK inhaled therapies developer Vectura Group says that it has triggered a further milestone associated…

FinancialPharmaceuticalResearchRespiratory and PulmonaryVectura GroupVR315

AstraZeneca’s olaparib shows success in tumor response rate for patients with BRCA-related cancers

07-11-2014

Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26%…

AstraZenecaLynparzaolaparibOncologyPharmaceuticalResearch

UK's NICE does not recommend Pfizer's Xiapex for Dupuytren's contracture

UK's NICE does not recommend Pfizer's Xiapex for Dupuytren's contracture

07-11-2014

The UK’s National Institute for Health and Care Excellence is consulting on provisional recommendations…

Anti-Arthritics/RheumaticsPfizerPharmaceuticalRegulationUKXiapex

Allergan is reportedly in takeover talks with Actavis

Allergan is reportedly in takeover talks with Actavis

07-11-2014

Botox maker Allergan is reportedly in merger talks with Ireland-headquartered generics major Actavis,…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSA

FDA advisory panel votes against approval of Novartis MM drug

07-11-2014

At a meeting yesterday, the US Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC)…

LBH589NovartisOncologypanobinostatPharmaceuticalRegulationUSA

Novel drugs from Anavex hope to reverse Alzheimer's damage amid a stagnant marketplace

Novel drugs from Anavex hope to reverse Alzheimer's damage amid a stagnant marketplace

06-11-2014

Alzheimer’s is not an easy disease to research and develop around. The physical and psychological manifestations…

AnavexBiotechnologyCNS DiseasesResearchUSA

Janssen’s Olysio/sofosbuvir combination cleared by FDA

Janssen’s Olysio/sofosbuvir combination cleared by FDA

06-11-2014

The Food and Drug Administration has approved US health care giant Johnson & Johnson's Olysio (simeprevir)…

Anti-viralsBiotechnologyJohnson & JohnsonMedivirOlysioRegulationsofosbuvirUSA

501 to 510 of 97252 results

Back to top